Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024

The academic health system is recognized for its pioneering use of technology, including artificial intelligence and digital innovation.

Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient care, improve care coordination and streamline hospital operations.

“As a leading academic health system, driving innovation is essential to our commitment to providing world-class care,” said John Couris, president and CEO of Tampa General Hospital. “This recognition demonstrates our team’s focus on adopting forward-thinking advancements in technology to maximize new approaches. The end result is better treatments and outcomes for patients now and long into future.”

The World’s Best Smart Hospitals 2024 rankings showcase the top 330 hospitals globally that are at the forefront of smart health care technologies. This recognition is the result of a comprehensive evaluation process that encompassed recommendations from more than 2,000 hospital managers and medical professionals across 28 countries. Hospitals were assessed in five key sub-categories:

Electronic functionalities
Telemedicine
Digital imaging
Artificial intelligence
Robotics

Tampa General’s journey to world-class care is guided by its vision of technology as a crucial element in delivering excellence. In the past year, the academic health system has implemented predictive analytics and artificial intelligence.

One standout example of Tampa General’s success in this realm is its partnership with GE Healthcare and the utilization of the CareComm command center. Similar to air traffic control, CareComm functions as a command center for patient care consistently gathering thousands of data points to provide insights, identify trends and drive decisions.

In 2022, Tampa General partnered with Palantir, a leading analytics platform to employ artificial intelligence (AI) capabilities to augment critical decision-making on the front lines. Both GE and Palantir have been instrumental in the development and execution of Tampa General’s early warning system for the prevention and treatment of sepsis, a potentially life-threatening response to an infection in the body that can move with lightning speed.

Clinical data was aggregated to predict the onset of sepsis and prioritize the activation of a rapid-response team intervention. The predictive analytics algorithm monitors real-time information from Tampa General’s electronic health record (EHR) and uses weighted rules-based logic to flag patients at high risk for sepsis.

As a result of this effort, the academic health system has seen a dramatic reduction in mortality from sepsis in patients admitted to the hospital. The mortality rate due to sepsis was reduced by 3% — which accounts for close to 200 lives saved since implementation.

“We’re honored to have earned a place among Newsweek’s World’s Best Smart Hospitals 2024. I attribute this recognition to the continuous innovation driven by our team,” said Scott Arnold, executive vice president and chief information officer at Tampa General Hospital. “The latest technologies taking the health care industry by storm — whether artificial intelligence, predictive analytics, telehealth, or something else — are the future of how we can better support our team members and deliver the best care possible to our community.”

For more information about the World’s Best Smart Hospitals 2024 rankings, please visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”